“Things are becoming more difficult.”Britain has long been a global leader in scientific research because of world-class universities that produce top scientific papers. European Union money accounted for 40 percent of funding for cancer research in Britain over the last decade, according to Digital Science, a consulting firm based in London. But shortly after the Brexit vote, he was turned away from a research network involving European partners. Supporters of Brexit have also said that the government can use money that would otherwise have been sent to Brussels on scientific research. Darrin M. Disley, the chief executive of the Horizon Discovery Group, a biotech company in Cambridge, supported Britain remaining in the European Union.

Source: International New York Times October 18, 2016 00:04 UTC